Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 496
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

  Table of Contents    
Year : 2020  |  Volume : 63  |  Issue : 3  |  Page : 345-346
From Editor's desk

MD; FIC Path; MIAC, DHA, Professor, Department of Pathology, Rohilkhand Medical College and Hospital, Bareilly, Uttar Pradesh, India

Click here for correspondence address and email

Date of Submission28-Jul-2020
Date of Acceptance29-Jul-2020
Date of Web Publication7-Aug-2020

How to cite this article:
Agrawal R. From Editor's desk. Indian J Pathol Microbiol 2020;63:345-6

How to cite this URL:
Agrawal R. From Editor's desk. Indian J Pathol Microbiol [serial online] 2020 [cited 2021 Jan 18];63:345-6. Available from: https://www.ijpmonline.org/text.asp?2020/63/3/345/291696

Dear Readers,

Warm greetings to you all. We are all facing great unprecedented situation. There has been a major transformation in our lifestyle as well as thought-process. In spite of all odds, the July–September 2020 issue of IJPM is out. Even in this grim situation, there is something to cheer up and be happy about. As per the recent In Cites Journal Citation Report for 2019, the impact factor for IJPM has been 0.663, which is a 27.26% jump from that of the last year.

The entire medical fraternity suffered a great setback with the passing away of the great pathologist Dr. Juan Rosai. He has been a pioneer in the field of Surgical Pathology. A pathologist par excellence, an eminent teacher, a great academician, and author of books including Ackerman's Text Book of Pathology will be greatly missed.

COVID-19 has created a global havoc in all the walks of life, especially in the medical field. Two review articles on this pandemic have been included in the present issue of IJPM. Article by Misra et al. is based on the guidelines recommended by the Indian Association of Pathologists and Microbiologists (IAPM) in relation to safeguarding of the laboratory personnel against COVID-19, while collecting, processing, or testing of potentially infectious samples. These safety measures are of prime importance.[1] Article by Bal et al. in a comprehensive manner has highlighted the epidemiological status, viral structure, clinical features, pathophysiology, pathology of the organs affected, laboratory diagnostic tests, and the preventive strategies of COVID-19.[2] These articles would serve as reference articles for all those looking for a complete literature on this viral disease.

Carcinoma breast is a leading cause of mortality in females. Various biomarkers have been used to predict early diagnosis and estimate the prognosis. The stromal fibroblast-induced gene (EPSTI-1) has been implicated in the trigger, invasion, metastases, and independent growth of carcinoma breast cells. Expression of this marker leads to disease extension, aggressive nature, and spread to distant sites.[3] Lengare et al. used cyclin D1 as an indicator for invasive carcinoma breast. In their study, they suggested including this marker along with the routine Immunohistochemistry (IHC) markers for better patient management and specific target therapy.[4] Same marker cyclin D1 has been used by Yildirim et al. for endometrioid endometrial carcinoma, showing correlation with the histological and nuclear grade and invasion into the myometrium, lymphovascular structure, or lymph nodes.[5] In another interesting article by Celik et al. on endometrioid endometrial carcinoma, the authors concluded that overexpression of TROP2 acts as a poor prognostic factor in these malignancies. Study of expression of these markers helps a clinician in choosing the mode of surgery, adjuvant therapy, and follow-up of these patients.[6]

Mahdavi et al. in their manuscript have tried to differentiate between the myofibroblasts and expression of matrix metalloproteinase in the adjacent stroma of verrucous hyperplasia and verrucous carcinoma of the oral cavity. This change helps in evaluating the lesions, especially in inadequate or disoriented samples.[7] Chromophobe renal cell carcinoma and renal oncocytoma originating from the same cell have distinct morphological features, but instances of overlapping morphology are reported. Role of MOC31, CD82, and AMY1A in distinguishing both the entities has been highlighted by the authors.[8] Preanalytical sample errors are a common cause of erroneous laboratory results. Gaur et al. in their extensive study concluded that inadequate sample quantity was one of the most important sources of preanalytical error.[9]

This time, we had an overwhelming response from the authors and a good number of original research articles have been submitted to IJPM. I would also like to state that numerous and repeated phone calls and e-mails are being sent to the editorial office regarding the publication status of their submitted manuscript. Authors need to understand that, for critically evaluating an article, it takes in a lot of hard work and time by the reviewers. The net outcome is a good-quality publication. Further, once an article is accepted, it further undergoes a thorough editing process which again takes time. Hence, it is requested that sufficient time be provided to the editorial office for working on the articles and refrain from repeated e-mails or calls.

All the members of IAPM are requested to kindly update their addresses especially their e-mail and mobile number so that they can be updated with the activities and decisions of the association. I am sure that this July–September 2020 issue of IJPM would be informative and full of knowledge for the readers. Wishing all the readers for their safety and happy reading.

   References Top

Misra V, Agrawal R, Kumar H, Kar A, Kini U, Poojary A, et al. Guidelines for various laboratory sections in view of COVID-19: Recommendations from the Indian Association of Pathologists and Microbiologists. Indian J Pathol Microbiol 2020;63:350-7.  Back to cited text no. 1
  [Full text]  
Bal A, Agrawal R, Vaideeswar P, Arava S, Jain A. COVID-19: An up-to-date review-from morphology to pathogenesis. Indian J Pathol Microbiol 2020;63:358-66.  Back to cited text no. 2
  [Full text]  
Raval AP, Desai UN, Joshi JS, Shah FD. Role of epithelial-stromal interaction protein-1 expression in breast cancer. Indian J Pathol Microbiol 2020;63:382-7.  Back to cited text no. 3
  [Full text]  
Lengare PV, Sinai Khandeparkar SG, Joshi AR, Gogate BP, Solanke SG, Gore SH. Immunohistochemical expression of cyclin D1 in invasive breast carcinoma and its correlation with clinicopathological parameters. Indian J Pathol Microbiol 2020;63:376-81.  Back to cited text no. 4
  [Full text]  
Yildirim HT, Nergiz D, Sadullahoglu C, Akgunduz Z, Yildirim S, Dogan S, et al. The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma. Indian J Pathol Microbiol 2020;63:412-7.  Back to cited text no. 5
  [Full text]  
Celik SY, Ilhan Celik O. Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma? Indian J Pathol Microbiol 2020;63:418-22.  Back to cited text no. 6
  [Full text]  
Mahdavi N, Amini Shakib P, Nabiyi P, Ghanadan A, Ghorbanpour M, Soluk-Tekkesin M. Evaluation of the presence of myofibroblasts and matrix metalloproteinase 1 expression in the stroma of oral verrucous hyperplasia and verrucous carcinoma. Indian J Pathol Microbiol 2020;63:369-75.  Back to cited text no. 7
  [Full text]  
Abouhashem NS, Aldelbary EH, Abdalla MM, El-Shazly M. Diagnostic utility of amylase α-1A, MOC 31, and CD82 in renal oncocytoma versus chromophobe renal cell carcinoma. Indian J Pathol Microbiol 2020;63:405-11.  Back to cited text no. 8
  [Full text]  
Gaur K, Puri V, Shukla S, Sharma S, Suman S, Singh R. Finish before the start: Analyzing preanalytical sample errors in a tertiary care hematology laboratory. Indian J Pathol Microbiol 2020;63:435-40.  Back to cited text no. 9
  [Full text]  

Correspondence Address:
Ranjan Agrawal
MD; FIC Path; MIAC, DHA, Professor, Department of Pathology, Rohilkhand Medical College and Hospital, Bareilly, Uttar Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/IJPM.IJPM_922_20

Rights and Permissions


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded70    
    Comments [Add]    

Recommend this journal